Cumberland Pharmaceuticals (CPIX) Profit After Tax Growth (3y) (2013 - 2026)
Cumberland Pharmaceuticals (CPIX) Profit After Tax Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 14.01% |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 2.89% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 8.71% |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -34.81% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 15.37% |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 36.74% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 117.61 Mn | 113.74 Mn | - | -90.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -90.41% |
| Mar 31, 2026 | -176.30% |
| Dec 31, 2025 | 16.35% |
| Sep 30, 2025 | -66.37% |
| Jun 30, 2025 | 18.43% |
| Mar 31, 2025 | 42.54% |
| Dec 31, 2024 | 20.94% |
| Sep 30, 2024 | -13.35% |
| Jun 30, 2024 | -51.80% |
| Mar 31, 2024 | -75.70% |
| Dec 31, 2023 | -92.48% |
| Sep 30, 2023 | -29.63% |
| Jun 30, 2023 | 43.42% |
| Mar 31, 2023 | 27.88% |
| Dec 31, 2022 | -36.45% |
| Sep 30, 2022 | 49.65% |
| Jun 30, 2022 | -35.42% |
| Mar 31, 2022 | -166.76% |
| Dec 31, 2021 | -20.12% |
| Sep 30, 2021 | 13.72% |